The University of Chicago Header Logo

Connection

Mark Talamonti to Capecitabine

Back to Details
This is a "connection" page, showing publications Mark Talamonti has written about Capecitabine.
Mark Talamonti
Connection Strength
0.033
Capecitabine
  1. Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101. JAMA Surg. 2016 08 17; 151(8):e161137.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.